Marjorie Taylor Greene
Stock Price at Trade vs. Today
Real market data showing how each stock moved since the congress member traded it.
Suspicious Timing Detected
5 flagsMarjorie Taylor Greene bought $1,001 - $15,000 in $LLY on 2025-05-14, 5 days before the DeOndra Dixon INCLUDE Project Act of 2025 (HR3491) was introduced and referred to the Committee on Energy and Commerce.
Marjorie Taylor Greene bought $1,001 - $15,000 in $NVDA on 2025-05-14, 8 days before the Access Technology Affordability Act of 2025 (S1918) was introduced, which proposes a tax credit for assistive technology.
Marjorie Taylor Greene bought $1,001 - $15,000 in $AMGN on 2025-05-14, 22 days before the Treat and Reduce Obesity Act of 2025 (S1973) was introduced, aiming to expand Medicare coverage for obesity treatments.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | Treasury Bill | US Treasury Bill(Treasury Bill) | $100K-$250K | — | — | — | May 16, 2025 |
| BUY | $MELI | MercadoLibre, Inc. - Common Stock (MELI) | $15K-$50K | — | $1,835.22 | — | May 14, 2025 |
| BUY | $UNH | UnitedHealth Group Incorporated Common Stock (UNH) | $15K-$50K | — | — | — | May 14, 2025 |
| BUY | $AMD | Advanced Micro Devices, Inc. (AMD) | $1K-$15K | — | $347.81 | — | May 14, 2025 |
| BUY | $GOOG | Alphabet Inc. - Class C Capital Stock (GOOG) | $1K-$15K | — | — | — | May 14, 2025 |
| BUY | $AMGN | Amgen Inc. - Common Stock (AMGN) | $1K-$15K | — | — | — | May 14, 2025 |
| BUY | $BX | Blackstone Inc. Common Stock (BX) | $1K-$15K | — | — | — | May 14, 2025 |
| BUY | $CAH | Cardinal Health, Inc. Common Stock (CAH) | $1K-$15K | — | — | — | May 14, 2025 |
| BUY | $CVX | Chevron Corporation Common Stock (CVX) | $1K-$15K | — | $185.21 | — | May 14, 2025 |
| BUY | $GLW | Corning Incorporated Common Stock (GLW) | $1K-$15K | — | — | — | May 14, 2025 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
Stop the Scroll Act
The 'Stop the Scroll Act' (S.1885) mandates mental health warning labels on social media platforms, increasing operational costs and potentially decreasing user engagement, directly impacting advertising revenue models. The bill is in the early stages, having been referred to the Committee on Commerce, Science, and Transportation. This regulatory burden creates a bearish outlook for social media companies.
Treat and Reduce Obesity Act of 2025
The Treat and Reduce Obesity Act of 2025 (S.1973) is in early legislative stages, aiming to expand Medicare coverage for obesity treatments, including GLP-1 agonists and intensive behavioral therapy. This bill, if enacted, would significantly increase the total addressable market for pharmaceutical companies producing obesity drugs and manufacturers of related medical devices. Companies like Eli Lilly and Company ($LLY) and Novo Nordisk A/S ($NVO) are positioned to benefit from this potential market expansion.
DeOndra Dixon INCLUDE Project Act of 2025
The DeOndra Dixon INCLUDE Project Act of 2025 (HR3491) has been introduced in the House and referred to the Committee on Energy and Commerce. This bill authorizes the NIH to establish a dedicated program for Down syndrome research, which could increase demand for genetic sequencing, diagnostic services, and pharmaceutical development. While the bill does not appropriate funds, it sets the framework for future funding opportunities.
Lowering Broadband Costs for Consumers Act of 2025
The 'Lowering Broadband Costs for Consumers Act of 2025' (HR4032) mandates increased Universal Service Fund contributions from broadband and 'edge providers,' directly raising operating costs for major internet service providers and large technology companies. This will reduce profit margins for affected companies. The bill is in the early stages, having been referred to committee, but has a companion bill (S1651) and 23 cosponsors, indicating moderate legislative momentum.
Supporting Healthy Moms and Babies Act
The 'Supporting Healthy Moms and Babies Act' (HR3762) has been introduced in the House and referred to three committees. This bill mandates comprehensive coverage for maternal and newborn care without cost-sharing, which would increase revenue for healthcare providers and diagnostic companies, while increasing costs for health insurers. The bill is in its early stages, with a companion bill (S1834) also introduced in the Senate.
Small Biotech Innovation Act
The Small Biotech Innovation Act (HR3731) is in an early legislative stage, aiming to exempt research and development-intensive small biotech manufacturers from Medicare drug price negotiations. While the bill could protect future revenue streams for qualifying small biotech firms, there is no direct market reaction evident in the provided stock data for either large or small biotech firms.
Association Health Plans Act
The Association Health Plans Act (S.1847) is an early-stage bill that aims to increase competition for large health insurers by expanding self-funded health plan options for small businesses. This legislation, if enacted, would reduce regulatory burdens for participating employers, shifting market share and revenue away from traditional health insurance providers. Large, publicly traded health insurance companies would experience reduced enrollment and revenue.
Access Technology Affordability Act of 2025
The Access Technology Affordability Act of 2025 introduces a refundable tax credit of up to $2,000 every three years for the purchase of qualified access technology for blind individuals. This directly increases consumer purchasing power for specific technology products, creating a new demand channel for companies in the assistive technology space.
RAMP Act
The RAMP Act (HR4056) is in early legislative stages, aiming to reduce legal exposure for non-group health insurers in Medicare secondary payer cases. This bill restricts private rights of action to only group health plans, directly benefiting healthcare insurers by limiting litigation risk. UnitedHealth Group, Cigna, and Humana are positioned to benefit from this regulatory relief.
Tackling Predatory Litigation Funding Act
HR3512, the 'Tackling Predatory Litigation Funding Act,' proposes a new federal tax on income from litigation received by third-party funders, directly targeting their revenue. This bill, currently in the early stages, would significantly reduce the profitability of litigation finance, leading to a contraction in the market. Companies like Blackstone, KKR, and Apollo, which have exposure to alternative asset management including litigation finance, could face headwinds if this legislation progresses.
Live Charts
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.